Company / Current Liabilities per Share
RHYTHM PHARMACEUTICALS, INC. Current Liabilities per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities per Share
$1.70
FY2025
5-year range
$0.76 / $1.94
FY2021-FY2025
Trend
-12.6%
vs FY2024
Sector context
#74 of 210
Health Care
What the data says
At $1.70, RHYTHM PHARMACEUTICALS, INC.'s current liabilities per share ranks #137 of 210 in the Health Care sector. Current Liabilities per Share has fluctuated over the past 10 years, ranging from $0.41 in FY2020 to $1.94 in FY2024.
Based on SEC 10-K filings.
1.70 in FY2025 with a 5-year CAGR of +33.0%.
Increased from $0.98 to $1.70 over the past 2 years.
Health Care sector context is included.
Current Liabilities per Share over time
Growth rates
- 3-Year CAGR
- +30.5%
- 5-Year CAGR
- +33.0%
- 10-Year CAGR
- -
Sector benchmark
-92.9% below sector average
Key checks
Key Insights
- In FY2025, current liabilities per share decreased 12.6% year-over-year.
- Ranks #74 out of 210 companies in the Health Care sector.
- Peak current liabilities per share was recorded in FY2024.
- Lowest current liabilities per share in the period was in FY2020.
Company context
Key Data Points
- Altman Z-Score -2.52 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Liabilities per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.70 | -12.6% |
| FY2024 | $1.94 | +99.3% |
| FY2023 | $0.98 | +27.7% |
| FY2022 | $0.76 | -12.8% |
| FY2021 | $0.88 | +114.7% |
| FY2020 | $0.41 | -39.2% |
| FY2019 | $0.67 | +34.7% |
| FY2018 | $0.50 | -24.5% |
| FY2017 | $0.66 | +42.0% |
| FY2016 | $0.46 | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026